Abstract
To monitor the number of cycles of oral contraceptives distributed commercially in Thailand it is recommended that the data be collected quarterly from each pharmaceutical company. Data would benefit companies by showing their share of the market and the government by identifying trends. Early analyses demonstrate commercial distribution accounts for 94% of total oral contraceptive market and for 43% of the estimated total contraceptive practice in the country.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
